Results 191 to 200 of about 329,301 (347)

Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt   +15 more
wiley   +1 more source

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

open access: yesEuropean Journal of Heart Failure, EarlyView.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard   +29 more
wiley   +1 more source

A conservative treatment for eosinophilic cystitis

open access: yesIJU Case Reports, Volume 6, Issue 1, Page 8-12, January 2023., 2023
Introduction Eosinophilic cystitis is a rare condition which causes common symptoms and may mimic other conditions. Eosinophilic cystitis has several causes such as hypereosinophilic syndrome, inflammatory diseases, neoplasia, parasites or fungal infection, IgE‐related diseases, Drug Reaction and Eosinophilia and Systemic Symptoms (DRESS) syndrome, or ...
Franco Alchiede Simonato   +6 more
wiley   +1 more source

High-risk Genital-mucosal Human Papilloma Virus Types 58 and 59 Associated With Solitary Angiokeratoma on the Elbow

open access: yesDermatology Practical & Conceptual, 2023
Geeti Khullar   +3 more
doaj   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome

open access: yesIJU Case Reports, Volume 6, Issue 1, Page 33-36, January 2023., 2023
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial cancer in Lynch syndrome.
Ryosuke Oki   +7 more
wiley   +1 more source

Provision of a chlamydial culture service to a sexually transmitted diseases clinic. [PDF]

open access: bronze, 1982
G L Ridgway   +5 more
openalex   +1 more source

Building a dashboard to inform policy and clinical practice using the Irish epilepsy electronic patient record: Towards a learning health system

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives Ireland lags heavily in capacity and stakeholder interest for the development of learning health system tools. However, Ireland possesses a rich repository of electronic patient records for epilepsy patients stored at the National Epilepsy Centre at Beaumont Hospital.
Ian A. J. Darragh   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy